PRESS RELEASE published on 02/07/2024 at 00:43, 2 years 9 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights. The company aims to use the proceeds to accelerate debt deleveraging and strengthen strategic flexibility. Sartorius AG subscribed for approximately 400 million euros, representing approximately one-third of the Capital Increase Sartorius Stedim Biotech S.A. Debt Deleveraging EUR 1.2 Billion Share Capital Increase Sartorius AG
PRESS RELEASE published on 02/06/2024 at 18:13, 2 years 9 months ago Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding Sartorius Stedim Biotech S.A. launches a 1.2 billion euro share offering without shareholders' preferential subscription rights through bookbuilding process to reduce debt and enhance strategic flexibility Sartorius Stedim Biotech S.A. Share Offering Bookbuilding Process Debt Deleveraging Strategic Flexibility
PRESS RELEASE published on 02/01/2024 at 12:11, 2 years 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the total number of shares, theoretical voting rights, and net voting rights making up the issued capital, in accordance with regulatory requirements Voting Rights Capital Shares Sartorius Stedim Biotech SA Regulatory Filing
PRESS RELEASE published on 01/26/2024 at 07:00, 2 years 9 months ago Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook. The company expects sales revenue growth in the mid to high single-digit percentage range with an underlying profit margin of more than 30 percent. Keywords: Sartorius Stedim Biotech, preliminary results, fiscal 2023, 2024 guidance, midterm outlook. Preliminary Results Sartorius Stedim Biotech Fiscal 2023 2024 Guidance Midterm Outlook
PRESS RELEASE published on 11/02/2023 at 13:53, 3 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 10/19/2023 at 07:00, 3 years ago Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech
PRESS RELEASE published on 10/12/2023 at 21:05, 3 years 1 month ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
PRESS RELEASE published on 10/04/2023 at 10:02, 3 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 09/01/2023 at 15:38, 3 years 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 08/01/2023 at 14:08, 3 years 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 11/18/2026 at 00:35, 2 hours 40 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 3 hours 35 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 4 hours 15 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 5 hours 45 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 12 hours 15 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 01:55, 1 hour 19 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 1 hour 34 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/17/2026 at 23:13, 4 hours 1 minute ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 21:12, 6 hours 2 minutes ago EQS-Adhoc: JDC Group AG: Adjustment of Full-Year Guidance
Published on 11/17/2026 at 20:00, 7 hours 15 minutes ago EQS-Adhoc: Sasol Financing USA LLC: SASOL ANNOUNCES RESULTS OF THE INVITATION TO REPURCHASE OUTSTANDING US$750 MILLION 4.5% GUARANTEED SENIOR UNSECURED CONVERTIBLE BONDS DUE 2027
Published on 11/17/2026 at 18:00, 9 hours 15 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 17:45, 9 hours 30 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 19 hours 34 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.
Published on 11/17/2026 at 07:30, 19 hours 45 minutes ago PR_Carrefour reaffirms its confidence in the hypermarket model, a pillar of its performance
Published on 11/17/2026 at 06:55, 20 hours 20 minutes ago Recticel Group recognised by TIME among the World's Best Companies for Sustainable Growth 2027